• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Editors’ Picks

Editors’ Picks

human skin xenium© Wellcome Sanger Institute

Novel Human Skin Atlas reveals developmental secrets and potential for regenerative medicine

Human Skin Atlas, macrophages, Nature, Wellcome Sanger Institute, 16 October 2024/in E-News, Editors' Picks, Regenerative Medicine, Research /by panglobal

A groundbreaking study has mapped prenatal human skin at the cellular level, offering unprecedented insights into skin formation and hair follicle development. The research, which includes the creation of a novel skin organoid model, could pave the way for developments in treating congenital skin disorders and improving regenerative medicine approaches.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/human-skin-xenium-1-.jpg 675 844 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-16 17:05:492024-10-15 11:52:18Novel Human Skin Atlas reveals developmental secrets and potential for regenerative medicine
sleepy intern doctor

Night float vs Call: Study reveals impact on medical interns’ sleep and performance

call schedule, float schedule, medical interns, Research, sleep, 11 October 2024/in E-News, Editors' Picks, Research /by panglobal

A new study suggests that medical interns working on float schedules with concentrated night shifts experience better sleep regularity, mood, and cognitive performance compared to those on traditional call schedules with extended shifts.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/sleepy_doctor_intern.jpg 679 1018 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-11 17:10:132024-10-10 10:50:53Night float vs Call: Study reveals impact on medical interns’ sleep and performance
Erin Yamamoto, M.D., and Juan Piantino, M.D.©OHSU/Christine Torres Hicks

Brain’s waste clearance system definitively imaged in humans for the first time

brain, brain waste, glymphatic system, OHSU, world-first, 9 October 2024/in E-News, Editors' Picks, Neurology /by panglobal

Researchers at Oregon Health & Science University have provided the first definitive imaging evidence of the glymphatic system in human brains, confirming a long-hypothesised network of waste clearance pathways.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/OHSU_palatino_brain_waste.jpg 1000 1500 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-09 08:10:442024-10-09 08:10:44Brain’s waste clearance system definitively imaged in humans for the first time
80% of pregnant women affected by iron deficiency in third trimester

Study reveals 80% of pregnant women affected by iron deficiency in third trimester

anaemia, foetal iron accretion, iron deficiency, pregnancy, 26 September 2024/in E-News, Editors' Picks, Obs Gyn, Research, Women's Health /by panglobal

Researchers find over 80% of women are iron deficient by their third trimester despite the absence of anaemia in early pregnancy, even in high-resource settings, highlighting the need for improved screening and treatment protocols.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/pregnant_woman.jpg 745 926 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-26 09:35:182024-09-25 13:19:08Study reveals 80% of pregnant women affected by iron deficiency in third trimester
donanemab Kinsula

FDA under fire: Controversial Alzheimer’s drug donanemab approved amid excess death concerns and conflicts of interest

Alzheimer’s, donanemab, Eli Lilly, FDA, The BMJ, 26 September 2024/in dementia, E-News, Editors' Picks, Featured Articles, Patient Safety, pharmacology, Regulation /by panglobal

A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/donanemab_kinsula_web.jpg 800 1200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-26 02:00:412024-09-25 13:29:05FDA under fire: Controversial Alzheimer’s drug donanemab approved amid excess death concerns and conflicts of interest

Subtle word choices can significantly impact patient-clinician communication, study finds

communication, consultation, diagnosis, language, patient satisfaction, 24 September 2024/in E-News, Editors' Picks /by panglobal

New research highlights how small changes in clinicians’ language can affect patient outcomes, from diagnostic accuracy to treatment adherence.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/doctor-patient.jpg 876 1314 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-24 08:00:112024-09-25 13:39:32Subtle word choices can significantly impact patient-clinician communication, study finds
antimicrobial resistance

Antibiotic-resistant infections set to claim millions of lives by 2050, global study warns

antimicrobial resistance, future projections, infection, study, 23 September 2024/in E-News, Editors' Picks, Featured Articles /by panglobal

A groundbreaking analysis published in The Lancet predicts a steep rise in deaths from antimicrobial resistance, with older adults most at risk. The study offers a stark reminder of the urgent need for global action to combat this growing threat.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/AMR.jpg 784 1045 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-23 10:39:222024-09-23 10:39:22Antibiotic-resistant infections set to claim millions of lives by 2050, global study warns
GSC_JCI Healthcare Sustainability Certification

Joint Commission International unveils Healthcare Sustainability Certification

certification, environment, equity, JCI, sustainability, 12 September 2024/in E-News, Editors' Picks, Hospital Design, Sustainability /by panglobal

In a significant move towards addressing the healthcare sector’s environmental impact, Joint Commission International (JCI) has announced the launch of its Healthcare Sustainability Certification (HSC) programme. Developed in collaboration with the International Hospital Federation’s Geneva Sustainability Centre (GSC), this new certification is set to become available from 1 January 2025 for healthcare organisations outside the […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/GSC_JCI-Healthcare-Sustainability-Certification.png 810 1440 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-12 10:05:492024-09-12 10:05:49Joint Commission International unveils Healthcare Sustainability Certification

Groundbreaking technique renders skin transparent, opening new avenues for diagnostic imaging

diagnostics, food dye, skin, tartrazine, transparent, 5 September 2024/in E-News, Editors' Picks, Featured Articles, Imaging /by panglobal

Researchers have developed a novel method to make skin and underlying tissues transparent using a common food dye, heralding potentially far-reaching applications for a wide range of medical diagnostics and certain treatments.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/transparent_skin_2.jpg 1080 1920 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-05 20:01:592024-09-06 08:29:58Groundbreaking technique renders skin transparent, opening new avenues for diagnostic imaging
COVID-19 virus

New antibody neutralises all known SARS-CoV-2 variants

antibody, COVID-19, immunity, Research, SARS-CoV-2, SC27, 4 September 2024/in COVID 19, E-News, Editors' Picks, Featured Articles /by panglobal

A broadly neutralising antibody capable of protecting against all known SARS-CoV-2 variants and related coronaviruses has been discovered by researchers at the University of Texas at Austin.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/covid_virus.jpg 798 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-04 14:44:362024-09-04 14:44:36New antibody neutralises all known SARS-CoV-2 variants
Page 2 of 512345

Latest issue of International Hospital

April 2024

5 August 2025

Gates Foundation commits $2.5 billion to transform women’s health research

5 August 2025

Breakthrough brain imaging technology reveals neurovascular dynamics at cellular resolution

4 August 2025

Non-autoimmune diabetes discovered in African children challenges type 1 classification

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription